What does Glaucoma Eye Care do?

Glaucoma Eye Care is a specialist medical practice in Herent. Private Limited, started on 20 December 2023, 1 establishment.

What is the address of Glaucoma Eye Care?

The registered office of Glaucoma Eye Care is located at Snoy et d'Oppuerslaan 19, 3020 Herent.

Is Glaucoma Eye Care still active?

Yes. According to the CBE (15 November 2026) Glaucoma Eye Care is active, legal situation “Normale toestand”, started on 20 December 2023.

Is Glaucoma Eye Care registered on Peppol?

Yes, Glaucoma Eye Care is registered on the Peppol network with ID 0208:1003663552.

What is the enterprise number of Glaucoma Eye Care?

The enterprise number of Glaucoma Eye Care is BE1003663552.

When was Glaucoma Eye Care founded?

Glaucoma Eye Care was founded on 20 December 2023.

Who are the directors of Glaucoma Eye Care?

According to the 2025 annual accounts, the directors of Glaucoma Eye Care are: Evelien Vandewalle.

Is Glaucoma Eye Care a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 20 December 2023; 3 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 1 events from the Belgian Official Gazette processed.

How much profit did Glaucoma Eye Care make in 2025?

Glaucoma Eye Care posted a profit after taxes of € 211,089 in financial year 2025.

What is the revenue of Glaucoma Eye Care?

As a small company, Glaucoma Eye Care is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 276,481.

Glaucoma Eye Care (Private Limited) - Herent

Dossier Glaucoma Eye Care, printed on 15 November 2026 from databakkes.be/en/1003663552/glaucoma-eye-care. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Glaucoma Eye Care from Herent, company number BE1003663552, closed financial year 2025 with a result of € 211,089 after tax. For that financial year Glaucoma Eye Care recorded a gross margin of € 276,481 and equity of € 271,853. Compared with financial year 2024, the result moved from € 60,909 to € 211,089. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on March 20, 2026.

What it is worth Growing

€ 271,853

▲ € 211,089 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 211,089

▲ 247% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 152,883

▲ € 124,827 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 269,353.

People and assets in 2025

Vehicles and equipment

€ 3,808

▲ € 3,060 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 1,703

▼ 2% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 2,009

▼ 91% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 43,194

▲ 246% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year
	2023	2024	2025	Change 2024 → 2025
Gross margin	€ -1,786 Gross margin 2023: € -1,786 First fiscal year in the series	€ 77,276 Gross margin 2024: € 77,276 ▲ € 79,062 vs 2023 (€ -1,786) Favourable step	€ 276,481 Gross margin 2025: € 276,481 ▲ 258% vs 2024 (€ 77,276) Favourable step	▲ 258%
Profit after taxes	€ -1,786 Profit after taxes 2023: € -1,786 First fiscal year in the series	€ 60,909 Profit after taxes 2024: € 60,909 ▲ € 62,695 vs 2023 (€ -1,786) Favourable step	€ 211,089 Profit after taxes 2025: € 211,089 ▲ 247% vs 2024 (€ 60,909) Favourable step	▲ 247%
Equity	€ 714 Equity 2023: € 714 First fiscal year in the series	€ 60,764 Equity 2024: € 60,764 ▲ € 60,050 vs 2023 (€ 714) Favourable step	€ 271,853 Equity 2025: € 271,853 ▲ € 211,089 vs 2024 (€ 60,764) Favourable step	▲ € 211,089
Total debts	€ 3,498 Total debts 2023: € 3,498 First fiscal year in the series	€ 37,921 Total debts 2024: € 37,921 ▲ € 34,423 vs 2023 (€ 3,498) Unfavourable step	€ 48,402 Total debts 2025: € 48,402 ▲ 28% vs 2024 (€ 37,921) Unfavourable step	▲ 28%
Cash	€ 2,500 Cash 2023: € 2,500 First fiscal year in the series	€ 28,056 Cash 2024: € 28,056 ▲ € 25,556 vs 2023 (€ 2,500) Favourable step	€ 152,883 Cash 2025: € 152,883 ▲ € 124,827 vs 2024 (€ 28,056) Favourable step	▲ € 124,827
Retained profit	€ -1,786 Retained profit 2023: € -1,786 First fiscal year in the series	€ 58,264 Retained profit 2024: € 58,264 ▲ € 60,050 vs 2023 (€ -1,786) Favourable step	€ 269,353 Retained profit 2025: € 269,353 ▲ € 211,089 vs 2024 (€ 58,264) Favourable step	▲ € 211,089
Dividend	€ 0 Dividend 2023: € 0 First fiscal year in the series	€ 859 Dividend 2024: € 859 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 859) Unchanged	▼ 100%
Bank debt	€ 0 Bank debt 2023: € 0 First fiscal year in the series	€ 1,733 Bank debt 2024: € 1,733 Unchanged (€ 0) Unfavourable step	€ 1,703 Bank debt 2025: € 1,703 ▼ 2% vs 2024 (€ 1,733) Favourable step	▼ 2%
Balance sheet total	€ 4,212 Balance sheet total 2023: € 4,212 First fiscal year in the series	€ 98,685 Balance sheet total 2024: € 98,685 ▲ € 94,472 vs 2023 (€ 4,212) Unchanged	€ 320,255 Balance sheet total 2025: € 320,255 ▲ 225% vs 2024 (€ 98,685) Unchanged	▲ 225%

By gross margin, Glaucoma Eye Care ranks 12th of 32 companies with main activity “Activiteiten van medisch specialisten” in Herent that publish figures (fiscal year 2025).

Key figures of Glaucoma Eye Care, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

Ask about Glaucoma Eye Care the way you would ask their accountant.

Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.

Connect ChatGPT or Claude for free

ChatGPT
Claude

Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.

What happened to Glaucoma Eye Care?

What happened at Glaucoma Eye Care in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Mar 20, 2026 New annual accounts for financial year 2025: profit of € 211,089 (▲ 247% vs 2024). Source: NBB ↗
Dec 22, 2023 Incorporation, published in the Gazette. Source: Staatsblad ↗
Dec 20, 2023 New establishment in Herent. KBO
2023 Evelien Vandewalle became a director. NBB

In short

From € 1,786 loss in 2023 to € 211,089 profit in 2025.

Paid € 82,076 in corporate taxes since 2023.

Best year ever: 2025, with € 211,089 profit.

Paid out € 859 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Evelien Vandewalle

Glaucoma Eye Care

Behind Glaucoma Eye Care is Evelien Vandewalle.

Directors

According to the 2025 annual accounts

Evelien Vandewalle

Director

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Snoy et d'Oppuerslaan 19

3020 Herent

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Similar companies in Herent

Same main activity (Activiteiten van medisch specialisten), 35 active companies in Herent, largest first.

Dr.Leroux, oogarts - Dr.Ector, cardioloog

€ 1 million gross margin · 2025

DR. GERD FABRE

€ 724,041 gross margin · 2025

Dokter De Blauwe A.,oogarts

€ 588,913 gross margin · 2025

DOKTER THOMAS STEELANDT

€ 547,990 gross margin · 2025

Sara Ombelet

€ 521,885 gross margin · 2025

DR. MATHIEU STRUYVE

€ 474,704 gross margin · 2025

All companies with this activity → Largest companies in Herent →

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Incorporation

22 December 2023 Source: Deed ↗

Evelien Monica Vandewalle(oprichter) 100%

Details

Company number: 1003.663.552
VAT number: BE 1003.663.552
Registered office: Snoy et d'Oppuerslaan 19, 3020 Herent
Names & denominations: Glaucoma Eye Care
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 20 December 2023
Peppol: Active · Active since 18 Jun 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗